Eden Pharma Limited, a London-based company, announced on Friday the acquisition of 5,000 acres (about 2,000 hectares) in Uganda through a joint venture, which will be used for research and development of cannabis.
Uganda allowed the cultivation of medical cannabis in 2020 and is already an exporter of medical cannabis, especially to the UK.
Eden Pharma is a cannabis-focused research and development company founded in 2017.
“This project is licensed by the Ugandan government and aims to be the largest cannabis facility in the world. The site should conduct research on cannabis and its industry, and [générer] huge amounts of raw materials and CBD for markets around the world,” Eden said in a press release.
” The joint venture in Uganda offered Eden Pharma significant development opportunities. It will be a vertically integrated business,” the company added in reference to its business model and supply chain.
Eden Uganda Project
The company said that within three years of the completion of the Eden Uganda project, it expects its workforce to be 100% local.
According to Eden, the project is to “build a community for the local people”, create jobs, stimulate the local economy and improve the quality of life.
“This community will include infrastructure such as research labs, pharmacies and an airport.”
The company is also expected to increase Uganda’s GDP by 3%. A documentary film is currently in production. It shows land in Uganda and is titled “The Garden of Africa”.